Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and CYP2C19 and tricyclic antidepressants
Kristian Kleine Schaars, Marga Nijenhuis, Bianca Soree, Nienke de Boer-Veger, Anne-Marie Buunk, Henk-Jan Guchelaar, Elisa J. F. Houwink, Arne Risselada, Gerard A. P. J. M. Rongen, R van Schaik, Jesse J. Swen, Daan Touw, Vera H M Deneer, Roos van Westrhenen
Topics & Concepts
NortriptylineDoxepinClomipraminePharmacogeneticsMedicineCYP2D6PharmacologyAmitriptylineImipramineCYP2C19TricyclicGuidelineAnxietyGenotypingPharmacotherapyTricyclic antidepressantPsychiatryInternal medicineAnesthesiaPsychologyPhenprocoumonPharmacokineticsPharmacogenetics and Drug MetabolismTreatment of Major DepressionNeurotransmitter Receptor Influence on Behavior